BLU2864
BLU2864 is an orally active, highly selective, ATP-competitive PRKACA inhibitor with an IC50 of 0.3 nM, exhibiting anti-tumor activity and potential applications in cancer and polycystic kidney disease research .
Product Specifications
CAS Number
2810747-89-6
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
452.43
Molecular Formula
C24H19F3N4O2
Notes
Research use only, not for human use.
Receptor
Others
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15151635 1 Vial
Lentiviral human PRRX2 shRNA (UAS) - Lentiviral human PRRX2 shRNA (UAS, iRFP) (100)
Ask
View Details 
